Skip to main content

Carles Bravo Masgoret

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Carles Bravo Masgoret

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Projects

CIBER: Enfermedades respiratorias

IP: Ferran Morell Brotad
Collaborators: Carles Bravo Masgoret, Mª Jesús Cruz Carmona
Funding agency: CIBER en Enfermedades Respiratorias
Funding:
Reference: CB06/06/0030
Duration: 01/01/2007 - 31/12/2010

Investigación cooperativa en enfermedades respiratorias

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 43435
Reference: PI051344
Duration: 01/01/2006 - 31/12/2006

Unitat de Recerca de Pneumologia

IP: Ferran Morell Brotad
Collaborators: Antonio Román Broto, Patricia Lloberes Canadell, Carles Bravo Masgoret
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 32600
Reference: 2005SGR 00659
Duration: 01/01/2006 - 31/12/2008

Bases moleculares y fisiológicas de las enfermedades respiratorias. Implicaciones diagnósticas y terapéuticas.

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Carles Bravo Masgoret, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Mª Jesús Cruz Carmona, Albert Selva O'Callaghan, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 264070
Reference: C03/11
Duration: 01/01/2003 - 31/12/2005

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Cristina Avila Fumanal

Cristina Avila Fumanal

Growth and Development
Read more
Ana Moreno Fernández

Ana Moreno Fernández

Tècnic/a Grau Superior
Financial control
Finances Area
Read more
Anna Salas  Martinez

Anna Salas Martinez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Ernesto Melchor Guerra Farfan

Ernesto Melchor Guerra Farfan

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.